AOD-9604

This synthetic fragment contains just 15 amino acids from the tail end of human growth hormone, engineered to retain fat-burning properties while eliminating the growth effects that make full HGH problematic. Originally developed by an Australian biotech company, it gained attention from obesity researchers and anti-aging clinics before regulatory restrictions limited its availability. The peptide represents an attempt to isolate HGH's metabolic benefits without triggering unwanted growth in bones, organs, or other tissues.

AOD-9604 works by mimicking how the C-terminal region of growth hormone interacts with fat cells, specifically binding to receptors that control fat breakdown and storage. When it attaches to these receptors on adipocytes, it appears to accelerate lipolysis (the process where stored fat gets broken down into usable energy) while simultaneously putting the brakes on lipogenesis (new fat formation). Think of it as flipping two switches simultaneously—one that speeds up fat burning and another that slows down fat storage.